Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Legacy Wealth Asset Management LLC

Legacy Wealth Asset Management LLC lessened its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 63.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 205 shares of the medical instruments supplier’s stock after selling 363 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in Mettler-Toledo International were worth $273,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Eisler Capital UK Ltd. purchased a new position in Mettler-Toledo International during the fourth quarter valued at $770,000. Caprock Group LLC lifted its stake in shares of Mettler-Toledo International by 450.2% in the fourth quarter. Caprock Group LLC now owns 1,733 shares of the medical instruments supplier’s stock worth $2,102,000 after buying an additional 1,418 shares in the last quarter. Oak Thistle LLC purchased a new position in shares of Mettler-Toledo International in the fourth quarter worth about $1,419,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Mettler-Toledo International by 9.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 144,015 shares of the medical instruments supplier’s stock worth $174,684,000 after buying an additional 12,249 shares in the last quarter. Finally, Capital International Investors lifted its stake in shares of Mettler-Toledo International by 3.0% in the fourth quarter. Capital International Investors now owns 933,989 shares of the medical instruments supplier’s stock worth $1,132,891,000 after buying an additional 27,386 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Citigroup lifted their target price on shares of Mettler-Toledo International from $975.00 to $1,200.00 and gave the stock a “sell” rating in a research note on Monday, May 13th. StockNews.com downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Wednesday. Jefferies Financial Group reiterated an “underperform” rating and set a $1,250.00 price target (up from $1,230.00) on shares of Mettler-Toledo International in a research report on Monday, June 3rd. Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the company a “neutral” rating in a research report on Monday, May 13th. Finally, Stifel Nicolaus lifted their price target on shares of Mettler-Toledo International from $1,270.00 to $1,510.00 and gave the company a “buy” rating in a research report on Monday, May 13th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,267.50.

Mettler-Toledo International Price Performance

Shares of MTD stock traded down $2.97 during trading on Thursday, reaching $1,354.10. The company’s stock had a trading volume of 71,143 shares, compared to its average volume of 155,148. The company has a market capitalization of $28.92 billion, a price-to-earnings ratio of 37.97, a P/E/G ratio of 3.64 and a beta of 1.17. The stock’s 50-day moving average price is $1,407.76 and its 200 day moving average price is $1,296.75. Mettler-Toledo International Inc. has a 1-year low of $928.49 and a 1-year high of $1,535.86.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $8.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.61 by $1.28. The company had revenue of $925.95 million for the quarter, compared to analysts’ expectations of $879.72 million. Mettler-Toledo International had a net margin of 20.55% and a negative return on equity of 662.32%. Mettler-Toledo International’s revenue was down .3% compared to the same quarter last year. During the same period in the previous year, the company posted $8.69 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 40.13 EPS for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $1,528.43, for a total transaction of $458,529.00. Following the transaction, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at approximately $7,510,705.02. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CFO Shawn Vadala sold 300 shares of the stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $1,528.43, for a total value of $458,529.00. Following the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at approximately $7,510,705.02. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Thomas P. Salice sold 1,268 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $1,490.18, for a total transaction of $1,889,548.24. Following the completion of the sale, the director now directly owns 244 shares in the company, valued at $363,603.92. The disclosure for this sale can be found here. Insiders have sold a total of 3,278 shares of company stock valued at $4,871,849 in the last ninety days. 1.94% of the stock is currently owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.